PANAGORA ASSET MANAGEMENT INC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 90 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$658,843
+16371.1%
18,185
+12706.3%
0.00%
Q2 2021$4,000
-96.6%
142
-96.8%
0.00%
-100.0%
Q1 2021$117,000
-86.1%
4,463
-86.7%
0.00%
-80.0%
Q4 2020$844,000
-8.3%
33,534
-24.1%
0.01%
-16.7%
Q3 2020$920,000
-80.3%
44,169
-77.5%
0.01%
-80.0%
Q2 2020$4,663,000
+93.4%
196,352
+46.5%
0.03%
+76.5%
Q1 2020$2,411,000
-71.9%
134,042
-62.9%
0.02%
-56.4%
Q4 2019$8,569,000
-9.1%
361,251
+5.3%
0.04%
-9.3%
Q3 2019$9,426,000
-22.2%
342,999
-6.3%
0.04%
-20.4%
Q2 2019$12,111,000
-7.5%
366,003
-2.0%
0.05%
-6.9%
Q1 2019$13,087,000
+59.7%
373,483
+51.4%
0.06%
+52.6%
Q4 2018$8,197,000
-33.1%
246,740
+1.5%
0.04%
-17.4%
Q3 2018$12,244,000
-16.4%
243,183
-0.6%
0.05%
-20.7%
Q2 2018$14,646,000
+24.9%
244,721
-4.4%
0.06%
+26.1%
Q1 2018$11,726,000
+12.2%
256,040
-2.3%
0.05%
+17.9%
Q4 2017$10,447,000
-2.1%
262,165
-1.7%
0.04%
-7.1%
Q3 2017$10,666,000
-39.4%
266,655
-34.7%
0.04%
-40.8%
Q2 2017$17,597,000
+82.8%
408,293
+32.7%
0.07%
+77.5%
Q1 2017$9,629,000
+23.7%
307,640
-0.2%
0.04%
+11.1%
Q4 2016$7,783,000
+2.6%
308,226
+0.4%
0.04%0.0%
Q3 2016$7,589,000
+12.7%
306,867
-7.2%
0.04%
+9.1%
Q2 2016$6,736,000
+45.8%
330,677
+9.2%
0.03%
+43.5%
Q1 2016$4,619,000
+49.2%
302,872
+31.5%
0.02%
+53.3%
Q4 2015$3,096,000
+12.0%
230,355
+16.9%
0.02%0.0%
Q3 2015$2,765,000
-23.6%
197,061
-7.6%
0.02%
-16.7%
Q2 2015$3,620,000
+28.2%
213,176
-8.7%
0.02%
+28.6%
Q1 2015$2,823,000
+146.6%
233,484
+69.2%
0.01%
+133.3%
Q4 2014$1,145,000
-5.2%
137,985
-0.7%
0.01%0.0%
Q3 2014$1,208,000
-24.6%
139,011
-5.0%
0.01%
-25.0%
Q2 2014$1,602,000
+29.0%
146,302
+5.3%
0.01%
+33.3%
Q1 2014$1,242,000
+17.6%
138,911
-0.8%
0.01%
+20.0%
Q4 2013$1,056,000
+4.1%
140,056
+1.2%
0.01%0.0%
Q3 2013$1,014,000
+402.0%
138,356
+340.4%
0.01%
+400.0%
Q2 2013$202,00031,4180.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders